ustekinumab
janssen
['lunch', 'ustekinumab', 'crohn', 'ibd']
check out my poster today during lunch time at . aurora study showing the combination of post-induction il-12, il-23, and ust levels was associated with long-term response at 18 months and could represent a novel predictor of long-term clinical outcomes. #aurora 
Head of IBD at Mater Hospital Brisbane